You have 9 free searches left this month | for more free features.

alemtuzumab

Showing 1 - 25 of 145

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allogeneic Hematopoietic Cell Transplantation Trial (Alemtuzumab)

Not yet recruiting
  • Allogeneic Hematopoietic Cell Transplantation
  • Alemtuzumab
  • (no location specified)
Aug 12, 2022

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)

Completed
  • T-cell-prolymphocytic Leukemia
  • Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
  • Alemtuzumab
  • Cologne, Germany
    University Hospital Cologne
Dec 16, 2021

Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

Recruiting
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 23, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Alemtuzumab
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,

Terminated
  • Relapsing-Remitting Multiple Sclerosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Hamburg, Germany
  • +1 more
Mar 1, 2022

Multiple Sclerosis (MS) Trial in Dallas (Alemtuzumab)

Completed
  • Multiple Sclerosis (MS)
  • Alemtuzumab
  • Dallas, Texas
  • +1 more
Jan 24, 2022

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
Feb 15, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Münster (Alemtuzumab)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Alemtuzumab
  • Münster, Germany
    Universitätsklinikum Münster, Klinik für Allgemeine Neurologie
Oct 25, 2021

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab
  • +3 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022

Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)

Active, not recruiting
  • Sickle Cell Disease
  • Alemtuzumab
  • +3 more
  • Hackensack, New Jersey
    Hackensack University Medical Center
Feb 4, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

Neurofilaments for NEDA Assessing in MS

Terminated
  • Multiple Sclerosis
  • Alemtuzumab
  • London, England, United Kingdom
    Queen Mary University of London
Feb 9, 2022

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Alemtuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

Completed
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Alemtuzumab
  • +2 more
  • Paris, France
    Hôpital Necker-Enfants Malades
Apr 13, 2021

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Busulfan test dose
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Alemtuzumab
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Sickle Cell Disease Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Sickle Cell Disease
  • Alemtuzumab
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 28, 2022

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Alemtuzumab
  • +6 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Renal Transplantation Trial in United States (Alemtuzumab, rabbit antithymocyte globulin, Belatacept)

Completed
  • Renal Transplantation
  • Alemtuzumab
  • +5 more
  • San Francisco, California
  • +7 more
Jul 8, 2021